Riskpilot← Back to searchSign inGet full accessScandinavian Spine AB
ABActiveOrg 5567652390Vidblicksgatan 2Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20081 employees
Revenue 2024
SEK 708K
-18% vs 2023
EBITDA margin
4.5%
+3100% vs 2023
Equity ratio
-20.9%
Financial strength
Net profit 2024
SEK 32K
+3100% vs 2023
| Revenue | SEK 708K | -18% |
| EBITDA | SEK 32K | +3100% |
| Net profit | SEK 32K | +3100% |
| Total assets | SEK 86K | +87% |
| Equity | SEK -18K | +64% |
| Employees | 1 | — |
Legal name
Scandinavian Spine AB
Org number
5567652390
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
10 september 2008
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva handel med kirurgiska implantat och därmed förenlig verksamhet.
Address
Vidblicksgatan 2
Email
bjorn@scandinavianspine.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 747 | 757 | 652 | 861 | 708 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 8 | −80 | 135 | 1 | 32 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 8 | −80 | 135 | 1 | 32 |
| Net financials | 341 | −35 | — | — | — |
| Profit before tax | 350 | −115 | 134 | 1 | 32 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 350 | −115 | 134 | 1 | 32 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 282 | 97 | 71 | 46 | 86 |
| Equity | −70 | −185 | −51 | −50 | −18 |
| Long-term debt | 2 011 | 0 | 0 | 0 | 0 |
| Short-term debt | 341 | 282 | 122 | 96 | 103 |
| Total debt | 2 352 | 282 | 122 | 96 | 103 |
EBITDA margin
4.5%
This company
15.8%
Market median
-72% vs market
20202024
Equity ratio
-20.9%
This company
38.2%
Market median
-155% vs market
20202024
Return on equity
3200000.0%
This company
18.4%
Market median
+17391204% vs market
20202024
Net profit margin
4.5%
This company
8.1%
Market median
-44% vs market
20202024
Asset turnover
8.23×
This company
1.12×
Market median
+635% vs market
20202024
Debt / equity
5.78×
This company
0.62×
Market median
-832% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
LB | Audit | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Scandinavian Spine AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Börje Gunnar Andersson | Audit | 0 companies |
| Björn Thomas Karlsson | Board of Directors | 0 companies |
| Britt-Marie Christina Niklasson | Deputy Board Member | 0 companies |
| Barbro Catharina Edwards Bergquist | Deputy Board Member | 0 companies |